Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC3167395242;95243;95244 chr2:178546314;178546313;178546312chr2:179411041;179411040;179411039
N2AB3003290319;90320;90321 chr2:178546314;178546313;178546312chr2:179411041;179411040;179411039
N2A2910587538;87539;87540 chr2:178546314;178546313;178546312chr2:179411041;179411040;179411039
N2B2260868047;68048;68049 chr2:178546314;178546313;178546312chr2:179411041;179411040;179411039
Novex-12273368422;68423;68424 chr2:178546314;178546313;178546312chr2:179411041;179411040;179411039
Novex-22280068623;68624;68625 chr2:178546314;178546313;178546312chr2:179411041;179411040;179411039
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: A
  • RefSeq wild type transcript codon: GCT
  • RefSeq wild type template codon: CGA
  • Domain: Ig-152
  • Domain position: 53
  • Structural Position: 138
  • Q(SASA): 0.1528
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
A/V rs200920551 None 0.996 N 0.68 0.422 0.336892272479 gnomAD-4.0.0 4.77373E-06 None None None None N None 0 0 None 0 0 None 0 0 5.71661E-06 0 3.02425E-05

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
A/C 0.591 likely_pathogenic 0.5794 pathogenic -1.231 Destabilizing 1.0 D 0.799 deleterious None None None None N
A/D 0.9972 likely_pathogenic 0.9974 pathogenic -2.584 Highly Destabilizing 0.999 D 0.853 deleterious N 0.481816207 None None N
A/E 0.9901 likely_pathogenic 0.9904 pathogenic -2.301 Highly Destabilizing 1.0 D 0.777 deleterious None None None None N
A/F 0.898 likely_pathogenic 0.91 pathogenic -0.645 Destabilizing 1.0 D 0.849 deleterious None None None None N
A/G 0.4613 ambiguous 0.4683 ambiguous -1.734 Destabilizing 0.998 D 0.687 prob.neutral N 0.481816207 None None N
A/H 0.9931 likely_pathogenic 0.9932 pathogenic -2.334 Highly Destabilizing 1.0 D 0.833 deleterious None None None None N
A/I 0.4777 ambiguous 0.5168 ambiguous 0.444 Stabilizing 0.999 D 0.789 deleterious None None None None N
A/K 0.9967 likely_pathogenic 0.9967 pathogenic -1.353 Destabilizing 1.0 D 0.787 deleterious None None None None N
A/L 0.3001 likely_benign 0.3289 benign 0.444 Stabilizing 0.997 D 0.69 prob.neutral None None None None N
A/M 0.4698 ambiguous 0.5009 ambiguous 0.108 Stabilizing 1.0 D 0.781 deleterious None None None None N
A/N 0.9864 likely_pathogenic 0.9877 pathogenic -1.873 Destabilizing 1.0 D 0.852 deleterious None None None None N
A/P 0.9953 likely_pathogenic 0.9955 pathogenic -0.045 Destabilizing 1.0 D 0.791 deleterious N 0.481816207 None None N
A/Q 0.9837 likely_pathogenic 0.9839 pathogenic -1.509 Destabilizing 1.0 D 0.775 deleterious None None None None N
A/R 0.9905 likely_pathogenic 0.9901 pathogenic -1.654 Destabilizing 1.0 D 0.785 deleterious None None None None N
A/S 0.5377 ambiguous 0.5458 ambiguous -2.302 Highly Destabilizing 0.992 D 0.689 prob.neutral N 0.481816207 None None N
A/T 0.3514 ambiguous 0.3706 ambiguous -1.861 Destabilizing 0.884 D 0.491 neutral N 0.452186734 None None N
A/V 0.1917 likely_benign 0.2093 benign -0.045 Destabilizing 0.996 D 0.68 prob.neutral N 0.409318604 None None N
A/W 0.9949 likely_pathogenic 0.9952 pathogenic -1.55 Destabilizing 1.0 D 0.851 deleterious None None None None N
A/Y 0.9755 likely_pathogenic 0.9769 pathogenic -0.937 Destabilizing 1.0 D 0.852 deleterious None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.